Compare ArcelorMittal SA (MT) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ArcelorMittal SA vs Summit Therapeutics Inc — how do they compare? ArcelorMittal SA trades at $74.2 (market cap $55.88B), while Summit Therapeutics Inc trades at $15.35 (market cap $12.06B). The key difference: ArcelorMittal SA is far larger — about 4.6× Summit Therapeutics Inc's market cap, and ArcelorMittal SA pays a 0.81% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| MT | SMMT | |
|---|---|---|
Market Cap | $55.88B | $12.06B |
Sector | Basic Materials | Health |
52-Week High | $75.35 | $26.98 |
52-Week Low | $32.44 | $12.55 |
Enterprise Value | $65.45B | $11.39B |
Dividend Yield | 0.81% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ArcelorMittal SA
ArcelorMittal SA is involved in the steel industry. The company's operating segments include NAFTA
Read more on MT →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
